Literature DB >> 12464688

Of mice and models: improved animal models for biomedical research.

Ernesto Bockamp1, Marko Maringer, Christian Spangenberg, Stephan Fees, Stuart Fraser, Leonid Eshkind, Franz Oesch, Bernhard Zabel.   

Abstract

The ability to engineer the mouse genome has profoundly transformed biomedical research. During the last decade, conventional transgenic and gene knockout technologies have become invaluable experimental tools for modeling genetic disorders, assigning functions to genes, evaluating drugs and toxins, and by and large helping to answer fundamental questions in basic and applied research. In addition, the growing demand for more sophisticated murine models has also become increasingly evident. Good state-of-principle knowledge about the enormous potential of second-generation conditional mouse technology will be beneficial for any researcher interested in using these experimental tools. In this review we will focus on practice, pivotal principles, and progress in the rapidly expanding area of conditional mouse technology. The review will also present an internet compilation of available tetracycline-inducible mouse models as tools for biomedical research (http://www.zmg.uni-mainz.de/tetmouse/).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12464688     DOI: 10.1152/physiolgenomics.00067.2002

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  43 in total

Review 1.  Transgenic RNAi: Accelerating and expanding reverse genetics in mammals.

Authors:  Xu-Gang Xia; Hongxia Zhou; Zuoshang Xu
Journal:  Transgenic Res       Date:  2006-06       Impact factor: 2.788

2.  Rescue of the albino phenotype by introducing a functional tyrosinase minigene into Kunming albino mice.

Authors:  Dong Xiao; Ying Yue; Xin-Yan Deng; Bing Huang; Zhong-Min Guo; Yun Ma; Yi-Li Lin; Xun Hong; Huan Tang; Kang Xu; Xi-Gu Chen
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

3.  Identification of a rat model for usher syndrome type 1B by N-ethyl-N-nitrosourea mutagenesis-driven forward genetics.

Authors:  Bart M G Smits; Theo A Peters; Joram D Mul; Huib J Croes; Jack A M Fransen; Andy J Beynon; Victor Guryev; Ronald H A Plasterk; Edwin Cuppen
Journal:  Genetics       Date:  2005-06-18       Impact factor: 4.562

4.  "TOR"rents of excitement over rapamycin's antiepileptogenic potential.

Authors:  Lisa R Merlin
Journal:  Epilepsy Curr       Date:  2008 Nov-Dec       Impact factor: 7.500

Review 5.  Probing human cardiovascular congenital disease using transgenic mouse models.

Authors:  Paige Snider; Simon J Conway
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

6.  Targeted Deletion of Hsf1, 2, and 4 Genes in Mice.

Authors:  Xiongjie Jin; Binnur Eroglu; Demetrius Moskophidis; Nahid F Mivechi
Journal:  Methods Mol Biol       Date:  2018

7.  Comparative proteomic analysis of a cytosolic fraction from β3 integrin-deficient cells.

Authors:  Jason A Bush; Hideki Kitaura; Yuliang Ma; Steven L Teitelbaum; F Patrick Ross; Jeffrey W Smith
Journal:  Cancer Genomics Proteomics       Date:  2012-01       Impact factor: 4.069

Review 8.  Animals models of MCH function and what they can tell us about its role in energy balance.

Authors:  Pavlos Pissios
Journal:  Peptides       Date:  2009-05-15       Impact factor: 3.750

Review 9.  Interstitial calcinosis in renal papillae of genetically engineered mouse models: relation to Randall's plaques.

Authors:  Xue-Ru Wu
Journal:  Urolithiasis       Date:  2014-08-06       Impact factor: 3.436

10.  Tetracycline-controlled transgene activation using the ROSA26-iM2-GFP knock-in mouse strain permits GFP monitoring of DOX-regulated transgene-expression.

Authors:  Simone Wörtge; Leonid Eshkind; Nina Cabezas-Wallscheid; Bernard Lakaye; Jinhyun Kim; Rosario Heck; Yasmin Abassi; Mustafa Diken; Rolf Sprengel; Ernesto Bockamp
Journal:  BMC Dev Biol       Date:  2010-09-03       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.